The Trade and Investment Research Project (TIRP) is an independently funded project administered by the CCPA. TIRP pools the trade policy research resources and expertise of Canadian non-governmental organizations from a variety of sectors. It produces expert research on a wide range of important trade and investment policy issues.
Our publications are available to all at no cost. Please support the CCPA and help make important research and ideas available to everyone. Make a donation today.

Thursday, February 15 In 2023, the U.S. corporation Ruby River Capital launched a massive $20 billion trade challenge against Quebec’s decision to reject the company’s…

This week’s North American Leaders’ summit is soured by dubious challenges to Mexican food and energy sovereignty

Trade tensions surround prospective launch of Europe’s Carbon Border Adjustment Mechanism

Forestry-related firms made regular use of NAFTA’s controversial but expiring investor-state dispute settlement process. Why is Canada opening the door to ISDS claims from Indonesian…

Manifestement, la mise en pratique des licences obligatoires est loin d’être une panacée.

This July marked the second anniversary of the new Canada-United States-Mexico Agreement (CUSMA), the renegotiated North American Free Trade Agreement (NAFTA).

Canada’s trade preference programs should be improved to raise living standards and improve working conditions and environmental policies

CETA cannot and will never deliver on the promises made to the beef and pork sectors. It will, however, continue doing serious harm to our…

Five years ago, Canada’s free trade pact with Europe came into force. Well, some of it did at least.

In some areas, the Comprehensive Economic and Trade Agreement (CETA) is worse than we predicted. We present five reasons why we’re not celebrating its fifth…

Trade agreement doesn’t age well in a post-pandemic reality, with little mention of worker protections, environmental policy, or critical infrastructure.

Corporate lobbying and WTO pressure-cooker tactics killed the TRIPS waiver. Countries must find the courage to take on Big Pharma at home.
Read the latest research, analysis and commentary on issues that matter to you.
CCPA Updates